3 wins for Regeneron: Phase 3 trial success vs allergies
Regeneron’s itepekimab antibody treatment posts 3 wins in Phase 3 trials, showing significant improvement against both cat allergies and seasonal pollen allergies.
Read More
His three children: 4-year search ends in a shoot-out
After a 4-year search for NZ bushman Tom Phillips, a dramatic shoot-out finally leads to the recovery of his three children, who had been living off-grid.
Closer Concerns: 2 Key Fantasy Baseball Updates on Cubs
Breaking down the latest fantasy baseball news, including the Chicago Cubs’ closer concerns and a hamstring injury update for Phillies star Trea Turner. Who to add?
Children’s Resilience: Harry Shares 5 Inspiring Stories
On his return to the UK, Prince Harry praises the remarkable children’s resilience at the WellChild Awards, sharing powerful stories of their strength and spirit.
Men’s Tennis Legends: How Alcaraz Ranks at Age 22
At 22, Carlos Alcaraz is already a force. How does he compare to men’s tennis legends like Federer, Nadal, and Djokovic at the same age? We break it down.
nrg tx: 3 Biotech Firms Lead Latest Fundraising Round
Get the latest biotech fundraising news. Our tracker covers the most recent funding rounds for innovative companies like nrg tx, Epigenic, and other key players.
$1.5M Seed Round Funds Space Dots’ Orbital Threat Tech
Space Dots secures a $1.5M seed round to advance its platform for providing critical insights on orbital threats, aiming to enhance space situational awareness.
Pinecone Founder Edo Liberty on AI’s Future at Disrupt 2025
At TechCrunch Disrupt 2025, Pinecone founder Edo Liberty discusses why the next big AI breakthrough is rooted in search technology. Learn his key insights here.
PD-L1xVEGF Drug: 1st Global Data for SCLC from BioNTech
BioNTech and BMS reveal promising first global data for their new pd-l1xvegf drug, a novel bispecific antibody targeting Small Cell Lung Cancer (SCLC) patients.
no-confidence vote: 3 things to know after Bayrou’s ouster
French PM Bayrou has been ousted in a parliamentary no-confidence vote. We explore the key implications for France’s political future and what happens next.